Answers are grounded in this paper and cite their sources.
Composite hydrogel enhances antibacterial activity and promotes wound healing, indicating its potential for chronic wound management.
Chronic wound management requires multifunctional biomaterials integrating antibacterial and tissue‐repair capacities. To address this clinical demand, we developed a composite hydrogel by incorporating quercetin‐loaded TiO 2 @CNTs heterojunctions into chitosan, leveraging their complementary properties: chitosan's excellent biocompatibility as the matrix, quercetin's natural anti‐inflammatory effects, TiO 2 ’s photocatalytic antibacterial activity, and CNTs’ structural reinforcement. The TiO 2 @CNTs heterojunction was synthesized hydrothermally, with characterization confirming uniform TiO 2 dispersion on CNTs, anatase‐phase crystallinity, and robust interfacial bonding. The composite hydrogel showed thermoresponsive gelation at 37 °C, favorable porcine skin adhesion, and a porous microstructure. In vitro tests revealed >90% L929 fibroblast viability (25 µM quercetin optimal), enhanced cell migration, and hemolysis rates <5%. Antibacterial assays against Escherichia coli demonstrated significantly larger inhibition zones (18.2 ± 1.3 mm) and lower bacterial counts for the composite hydrogel than those for the chitosan‐only or control groups. In a rat skin wound model, the hydrogel achieved 60% wound closure at 7 days, outperforming the chitosan (50%) and control (40%) groups. Furthermore, histological and blood biochemical analyses confirmed no systemic toxicity, organ damage, or TiO 2 /CNT accumulation in major organs. This multifunctional hydrogel exhibits synergistic antibacterial, biocompatible, and pro‐healing properties, making it a promising candidate for advanced chronic wound care applications.
No takes yet. Share an insight, caveat, or question.
Zuo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: